Skip to content

Study to Determine the Effects of Continuous Intake of fermented milk drink on Cold-Like Symptoms and immunity index.

Study to Determine the Effects of Continuous Intake of fermented milk drink on Cold-Like Symptoms and immunity index. - Study to Determine the Effects of Continuous Intake of fermented milk drink on Cold-Like Symptoms and immunity index.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052964
Enrollment
200
Registered
2023-12-02
Start date
2023-12-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male/female adults

Interventions

Consumption of a fermented milk drink (1 bottle a day) for 4 weeks Consumption of an unfermented milk drink (1 bottle a day) for 4 weeks

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Males and females aged 20 to below 60 years at the time of consent acquisition. 2. Office workers or part-time employees who work indoors at least once a week. 3. Subjects who have a self-awareness of being prone to catching colds. 4. Subjects who can give informed consent to partake in this study, after being provided with an explanation of the protocol detail.

Exclusion criteria

Exclusion criteria: 1. Subjects who test positive for any one of the following in the preliminary examination: HBs antigen, HCV antibodies, syphilis antibodies, HIV antigens or antibodies. 2. Subjects who plan to receive any type of vaccine between the time of consent acquisition and the end of the study. 3. Subjects with chronic conditions such as chronic rhinitis or asthma, which could be difficult to distinguish from upper respiratory tract infections. 4. Subjects with severe hay fever who cannot restrict medication during the trial period (excluding eye drops and nasal sprays). 5. Subjects who experience abdominal symptoms (such as diarrhea, abdominal pain, bloating) upon consumption of dairy products. 6. Subjects who consume fermented dairy products (yogurt, lactic acid bacteria beverages) or lactobacillus preparations more than twice a week. 7. Subjects who regularly use Food for Specified Health Uses (FOSHU), Foods with Function Claims, or health food (including supplements) more than twice a week, which may potentially affect the study and cannot discontinue them from the time of consent acquisition. 8. Subjects who are taking medications (such as antibiotics, Intestinal preparations, laxatives) more than twice a week, which may potentially affect the trial, and cannot restrict their use during the study period. 9. Subjects who excessive alcohol intake. 10. Subjects who smoke heavily (not less than 21 cigarettes a day) 11. Subjects with having irregular life rhythms, such as extremely irregular eating habits or those working night shifts. 12. Subjects with an exercise routine of more than five times per week, each session lasting more than 30 minutes. *For reference, exercise is defined as activities corresponding to 7 METs or higher according to the METs table published by the Ministry of Health, Labour and Welfare.

Design outcomes

Primary

MeasureTime frame
Incidence rate of upper respiratory tract infection (cold) like symptoms

Secondary

MeasureTime frame
Severity of upper respiratory tract infection (cold) like symptoms at onset Immunity index of peripheral blood Questionnaire on physical condition

Countries

Japan

Contacts

Public ContactMasanori Numa

CPCC Company Limited Clinical Planning Department

cpcc-contact@cpcc.co.jp03-6225-9001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026